The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction - Université de Reims Champagne-Ardenne Accéder directement au contenu
Article Dans Une Revue Oncotarget Année : 2016

The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction

Dates et versions

hal-03588688 , version 1 (25-02-2022)

Identifiants

Citer

Jean-Baptiste Oudart, Manon Doué, Alexia Vautrin, Bertrand Brassart, Christèle Sellier, et al.. The anti-tumor NC1 domain of collagen XIX inhibits the FAK/ PI3K/Akt/mTOR signaling pathway through αvβ3 integrin interaction. Oncotarget, 2016, 7 (2), pp.1516-1528. ⟨10.18632/oncotarget.6399⟩. ⟨hal-03588688⟩

Collections

CNRS URCA MEDYC
12 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More